Starboard worth is said to be taking a stake in Bristol-Myers Squibb – Bloomberg

[ad_1]

1. Starboard worth is said to be taking a stake in Bristol-Myers Squibb's Bloomberg
2. Bristol-Myers suspended its Celgene offer a few days before the deadline and got a better price FiercePharma
3. Playing hard, Bristol-Myers bought a Celgene battered with last-minute terms softened in his favor
4. Acquisition of Celgene as part of a "stimulating" deal for BioSpace, the Bristol-Myers Squibb investor
5. What does BMS say about its Celgene backstage purchase? This transcription tells FiercePharma
6. View full coverage on Google News

[ad_2]
Source link